HYPR Hyperfine Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HYPR

Price (delayed)

$1.505

Market cap

$149.4M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.4

Enterprise value

$121.25M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 20
Highlights
The gross profit has grown by 45% YoY and by 16% from the previous quarter
Hyperfine's revenue has increased by 31% YoY and by 13% QoQ
The company's quick ratio rose by 28% QoQ but it fell by 9% YoY
The equity is down by 20% year-on-year and by 16% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Peers: OBIO OM

Key stats

What are the main financial stats of HYPR

HYPR stock price

How has the Hyperfine stock price performed over time
Intraday
1.01%
1 week
-5.94%
1 month
-16.85%
1 year
112.21%
YTD
53.68%
QTD
39.35%

Financial performance

How have Hyperfine's revenue and profit performed over time
Revenue
$15.33M
Gross profit
$7.85M
Operating income
-$34.74M
Net income
-$34.78M
Gross margin
51.2%
Net margin
-226.9%
The gross profit has grown by 45% YoY and by 16% from the previous quarter
The operating margin has increased by 39% year-on-year and by 17% since the previous quarter
The net margin is up by 34% year-on-year and by 13% since the previous quarter
Hyperfine's revenue has increased by 31% YoY and by 13% QoQ

Price vs fundamentals

How does HYPR's price correlate with its fundamentals

Growth

What is Hyperfine's growth rate over time

Valuation

What is Hyperfine stock price valuation
P/E
N/A
P/B
4.29
P/S
9.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.91
The EPS rose by 26% YoY and by 7% QoQ
HYPR's P/B is 52% above its last 4 quarters average of 2.8
The equity is down by 20% year-on-year and by 16% since the previous quarter
HYPR's price to sales (P/S) is 38% less than its 5-year quarterly average of 15.4 but 32% more than its last 4 quarters average of 7.2
Hyperfine's revenue has increased by 31% YoY and by 13% QoQ

Efficiency

How efficient is Hyperfine business performance
HYPR's ROE is down by 37% YoY and by 4% QoQ
The ROS rose by 34% YoY and by 14% QoQ
Hyperfine's return on invested capital has increased by 22% QoQ and by 12% YoY
Hyperfine's ROA has decreased by 10% YoY but it has increased by 5% from the previous quarter

Dividends

What is HYPR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HYPR.

Financial health

How did Hyperfine financials performed over time
The company's total assets is 132% higher than its total liabilities
The total liabilities has surged by 153% year-on-year and by 82% since the previous quarter
The company's quick ratio rose by 28% QoQ but it fell by 9% YoY
The debt is 62% smaller than the equity
The equity is down by 20% year-on-year and by 16% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.